QSAR as a Tool for the Development of Potent Antiproliferative Agents by Inhibition of Choline Kinase

E-ISSN： 1875-6697|3|4|297-313

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.3, Iss.4, 2007-12, pp. : 297-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

(Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs

Current Medicinal Chemistry, Vol. 13, Iss. 11, 2006-05 ,pp. : 1231-1248

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR-Derived Choline Kinase Inhibitors: How Rational can Antiproliferative Drug Design Be?

Current Medicinal Chemistry, Vol. 10, Iss. 13, 2003-07 ,pp. : 1095-1112

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 188-204

Bentham Science Publishers

Access to resources Recommend Favorite

LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase

By Campos J. del Carmen Nunez M. Rodrguez V. Entrena A. Hernandez-Alcoceba R. Fernandez F. Lacal J.C. Gallo M.A. Espinosa A.

European Journal of Medicinal Chemistry, Vol. 36, Iss. 3, 2001-03 ,pp. : 215-225

Elsevier

Access to resources Recommend Favorite

QSAR Studies for the Pharmacological Inhibition of Glycogen Synthase Kinase-3

Medicinal Chemistry, Vol. 3, Iss. 4, 2007-07 ,pp. : 393-417

Bentham Science Publishers

Access to resources Recommend Favorite